LAS VEGAS, NV--(NewMediaWire - Nov 2, 2017) - Freedom Leaf, Inc.
(OTCQB: FRLF) is very pleased to announce that Paul Pelosi Jr.
has accepted our invitation to become Chairman of Freedom Leaf's
Board of Directors, effective immediately. Mr. Pelosi will
guide FRLF in corporate governance,
sustainable revenue generation, and investor relations. Freedom
Leaf, Inc. will launch an Initiative to become the model for
corporate governance in the cannabis and hemp sector.
Mr. Paul Pelosi Jr. is the son of U.S. House Minority Leader
Nancy Pelosi and has an extensive career advising companies on
corporate governance, sustainability, and public policy. Mr. Pelosi
graduated Cum Laude from Georgetown University with a Bachelor of
Arts, and holds an MBA with an emphasis in International Business.
Previously, Mr. Pelosi has served as the President of the SF
Commission on the Environment and was the founding member of Cisco
Systems Connected Urban Development team.
Mr. Pelosi is currently Executive Director of
the Corporate Governance
Initiative (CGI), an organization
that is committed to assisting companies adhere to a system of
guidelines, practices, and procedures by which a company is
directed and controlled. The Corporate Governance
Initiative also helps companies create policies to
find better balance between the interests of a company's many
stakeholders, such as shareholders, management, patrons, providers,
investors, government and the public.
Prior to CGI, Mr. Pelosi has served
organizations at the executive and leadership levels, and has a
wide scope of prospective and understanding when it comes to
business. Mr. Pelosi has experience advising both emerging
start-ups and Fortune 500 companies, including Bank of America, JP
Morgan, Airpatrol Corporation, and the NASA Ames Research
Center.
In 2018, Freedom Leaf, Inc. will be focused on shaping revenue
strategy and monitoring performance of its core and ancillary
businesses and investments. As revenue is the key to any successful
enterprise, Freedom Leaf's concentration on revenue generation is
moving the Company toward a major revenue increase with the launch
of the Hempology brands
and Green Market Europe.
Mr. Pelosi stated, "I will use my influence and best efforts to
make Freedom Leaf the foremost advocate and example of corporate
governance in the emerging cannabis and industrial hemp business
sector. Additionally, I strongly believe that the importance of
driving revenue in order to increase the value for the shareholders
is an important goal of a company, while still treating all other
stakeholders fairly. The Freedom Leaf network is an important tool
to provide factual information about the powerful benefits of
cannabis. For example, veterans and first responders can develop
PTSD and other maladies that result in physical and non-physical
pain. The pharmaceutical industry has prescribed opiates to
alleviate this pain, but has resulted in the opiate addiction
crisis that we are dealing with today. It is almost impossible
to withdraw from opiate addiction without some sort of aid, and
cannabis seems to be a perfect way to aid in the removal of this
addiction. It is also interesting that the states which have
legalized medical marijuana are states with dramatically fewer
opiate overdose deaths. For this reason I am excited to work with
Freedom Leaf to produce factual information and products centered
around the benefits of cannabis and CBD."
Freedom Leaf's Co-Founder and CEO, Cliff Perry, stated, "I am
proud that Mr. Pelosi thinks highly of Freedom Leaf's prospects and
our commitment to the mission of marijuana and hemp legalization.
We are looking forward to working closely with Paul to build our
company in a way that adheres to the highest standards of Corporate
Governance and pursues revenue-enhancing mergers and
acquisitions."
Freedom Leaf Co-Founder, Richard Cowan, added, "From the
beginning, we have been trying to build a company that combines
activism and entrepreneurialism. And given his background in
business, politics, and public interest advocacy, I cannot imagine
anyone better qualified than Paul Pelosi Jr. for such an
effort. We believe that with Paul's involvement with Freedom
Leaf we can develop economies of scale that will make it simpler
and more economical for our companies and others in our industry to
do it right, as we lead by example. Even though being a public
company involves costs and financial burdens on management for
legal compliance and good corporate governance, our fundamental
business plan has always centered around being in 100% compliance
to spin off new public companies for our projects, as they reach an
appropriate level of development."
About Freedom Leaf
Freedom Leaf, Inc., The Marijuana Legalization Company™, is a
fully reporting and audited, publicly traded company trading under
the symbol (OTCQB: FRLF). Freedom Leaf, Inc. is a leading
go-to resource in the cannabis, medical marijuana, and industrial
hemp industry. It is involved in mergers and acquisitions and
business consulting in the marijuana industry, including
incubation/acceleration and spin offs of new marijuana/hemp related
companies.
Freedom Leaf, Inc.'s flagship publication is Freedom Leaf
Magazine, "The Good News in Marijuana Reform." The company produces
a portfolio of news, print and digital multi-media verticals,
websites, blogs and web advertising, for the ever-changing emerging
cannabis, medical marijuana and industrial hemp industry.
Freedom Leaf, Inc. does not handle, grow, sell, or
dispense marijuana.
All of our European activities are in full compliance
with relevant EU laws.
Investor relations information can be found on
the FreedomLeafInc.com company
website.
Safe Harbor Statement
Statements in this press release that are not strictly
historical are "forward-looking" statements within the meaning of
Section 27A of the Securities Act of 1933, as amended and Section
21E of the Securities Exchange Act of 1934, as amended. These
forward-looking statements, including any financial projections
above, generally can be identified by phrases such as Freedom Leaf,
Inc. or its management "believes," "expects," "anticipates,"
"foresees," "forecasts," "estimates" "projections" or other words
or phrases of similar import. Similarly, statements herein that
describe the Company's business strategy, outlook, objectives,
plans, intentions or goals also are forward-looking statements. All
such forward-looking statements are subject to certain risks and
uncertainties that could cause actual results to differ materially
from those in forward-looking statements. Factors that could cause
or contribute to differences include the uncertainty regarding
viability and market acceptance of the Company's products and
services, changes in relationships with third parties, and other
factors described in the Company's most recent periodic filings
with the Securities and Exchange Commission, including its Annual
Report on Form 10-K dated June 30, 2017 and quarterly reports on
Form 10-Q.